Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.04% shed 2.23% to $168.07 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.30% falling 0.46% to 4,493.28 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.37% falling 0.43% to 34,879.38. This was the stock's third consecutive day of losses. Johnson & Johnson closed $11.85 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.64% fell 3.69% to $376.51, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.66% fell 2.04% to $73.82, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.64% fell 1.03% to $46.03. Trading volume (7.0 M) eclipsed its 50-day average volume of 5.6 M.